ENTEROCALM Trademark

Trademark Overview


On Monday, August 22, 2022, a trademark application was filed for ENTEROCALM with the United States Patent and Trademark Office. The USPTO has given the ENTEROCALM trademark a serial number of 97558629. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, September 17, 2024. This trademark is owned by Enterotarget ApS. The ENTEROCALM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of gastrointestinal disorders and diseases; Pharmaceutical and medicinal preparations and products for the treatment of gastrointestinal disorders and diseases; Anti-inflammatory drugs; Pharmaceutical and medicinal preparations for treatment, prevention, or alleviation of inflammatory conditions of the gastrointestinal tract; Pharmaceutical and medicinal preparations for treatment, prevention, or alleviation of inflammatory bowel disease (IBD); Pharmaceutical preparations for treatment, prevention, or alleviation of Crohn's disease and ulcerative colitis; Biotechnological preparations for medical use in the nature of anti-inflammatory preparations; Biological compounds for use in targeted pharmaceutical therapies for the treatment of gastrointestinal disorders and diseases; Drug delivery agents in the form of rectal solution, capsules, and tablets that facilitate the delivery of pharmaceutical pr...
enterocalm

General Information


Serial Number97558629
Word MarkENTEROCALM
Filing DateMonday, August 22, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, September 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 23, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of gastrointestinal disorders and diseases; Pharmaceutical and medicinal preparations and products for the treatment of gastrointestinal disorders and diseases; Anti-inflammatory drugs; Pharmaceutical and medicinal preparations for treatment, prevention, or alleviation of inflammatory conditions of the gastrointestinal tract; Pharmaceutical and medicinal preparations for treatment, prevention, or alleviation of inflammatory bowel disease (IBD); Pharmaceutical preparations for treatment, prevention, or alleviation of Crohn's disease and ulcerative colitis; Biotechnological preparations for medical use in the nature of anti-inflammatory preparations; Biological compounds for use in targeted pharmaceutical therapies for the treatment of gastrointestinal disorders and diseases; Drug delivery agents in the form of rectal solution, capsules, and tablets that facilitate the delivery of pharmaceutical preparations; Clinical medical reagents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, September 11, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEnterotarget ApS
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCopenhagen N 2200
DK

Party NameEnterotarget ApS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCopenhagen N 2200
DK

Trademark Events


Event DateEvent Description
Thursday, June 15, 2023NON-FINAL ACTION E-MAILED
Thursday, August 25, 2022NEW APPLICATION ENTERED
Sunday, September 11, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 8, 2023ASSIGNED TO EXAMINER
Thursday, June 15, 2023NON-FINAL ACTION WRITTEN
Thursday, June 15, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 30, 2023SUSPENSION LETTER WRITTEN
Wednesday, May 29, 2024FINAL REFUSAL E-MAILED
Friday, June 14, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, June 14, 2024EXAMINER'S AMENDMENT ENTERED
Friday, June 14, 2024EXAMINERS AMENDMENT E-MAILED
Friday, June 14, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 18, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, July 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 17, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 30, 2023LETTER OF SUSPENSION E-MAILED
Monday, October 30, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 2, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, May 1, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, May 29, 2024FINAL REFUSAL WRITTEN
Wednesday, May 29, 2024NOTIFICATION OF FINAL REFUSAL EMAILED